Casi Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 5.06, this represents a new company high. This is a clear indication for improving liquidity at Casi Pharmaceuticals Inc 's clients. Average receivable collection period, for the Casi Pharmaceuticals Inc in Dec 31 2025 quarter, has decreased to 72 days, compared to 88 days, in the 0 quarter.

If we take a look into Healthcare sector 398 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from to 2909.

What is Receivable Turnover Ratio?
What is Casi Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CASIF Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-73.33 %	-73.33 %	-73.33 %	-73.33 %	51.36 %
Y / Y Revenue Change	-27.42 %	-	-	-	-15.77 %
Receivable Turnover Ratio (TTM)	5.06	4.13	2.94	2.28	1.86
CASIF's Total Ranking	# 2909	#	#	#	#
Accounts Receivable average collection period days	72	88	124	160	196
Seq. Receivable Change	0 %	0 %	0 %	-73.33 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 118
Healthcare Sector	# 399
Overall Market	# 2909

Receivable Turnover Ratio Statistics
High	Average	Low
5.06	3.42	1.86
(Dec 31 2025)		(Dec 31 2024)

CASIF Company Profile • Back to CASIF Efficiency Comparisons • Compare CASIF Receivables Turnover Ratio to its Competitors

Financial Statements
Casi Pharmaceuticals Inc 's Accounts Receivable	$ 4 Millions	Visit CASIF's Balance sheet
Casi Pharmaceuticals Inc 's Sales TTM	$ 21 Millions	Visit CASIF's Income Statement
Sources of CASIF's Revenues		Visit CASIF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CASIF's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CASIF's Growth Rates	CASIF's Roa	CASIF's Inventory Turnover Ratio	CASIF's Dividend Comparisons
CASIF's Profitability Ratios	CASIF's Roi	CASIF's Asset Turnover Ratio	CASIF's Dividend Growth
CASIF's Valuation Ratios	CASIF's Roe	CASIF's Financial Strength Ratios	CASIF's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Aim Immunotech Inc	13.54	$ 0.088 Millions	$ 0.007 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
Inmed Pharmaceuticals Inc	13.26	$ 4.507 Millions	$ 0.340 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.18	$ 52.149 Millions	$ 3.957 Millions
Nexgel Inc	13.17	$ 10.509 Millions	$ 0.798 Millions
China Pharma Holdings Inc	13.14	$ 4.144 Millions	$ 0.315 Millions
Milestone Scientific Inc	12.98	$ 8.408 Millions	$ 0.648 Millions
Escalon Medical Corp	12.93	$ 12.311 Millions	$ 0.952 Millions
Dbv Technologies S a	12.63	$ 5.683 Millions	$ 0.450 Millions
Mannkind Corporation	12.49	$ 348.966 Millions	$ 27.948 Millions
Safe Pro Group Inc	12.46	$ 0.607 Millions	$ 0.049 Millions
Icu Medical Inc	12.35	$ 2,231.262 Millions	$ 180.620 Millions
Ensysce Biosciences Inc	12.27	$ 5.067 Millions	$ 0.413 Millions
Skinhealth Systems Inc	12.08	$ 300.364 Millions	$ 24.872 Millions
Corcept Therapeutics Inc	11.91	$ 761.407 Millions	$ 63.950 Millions
Option Care Health Inc	11.86	$ 5,648.895 Millions	$ 476.492 Millions
Cytokinetics Incorporated	11.74	$ 88.039 Millions	$ 7.499 Millions
Teladoc Health Inc	11.74	$ 2,529.977 Millions	$ 215.496 Millions
Lifestance Health Group Inc	11.71	$ 1,424.285 Millions	$ 121.659 Millions
Chemed Corporation	11.65	$ 2,529.978 Millions	$ 217.224 Millions
Orthofix Medical Inc	11.58	$ 822.017 Millions	$ 71.016 Millions
Lucid Diagnostics Inc	11.57	$ 4.706 Millions	$ 0.407 Millions
Integrated Biopharma Inc	11.30	$ 51.068 Millions	$ 4.521 Millions
Nrc Health	11.28	$ 137.390 Millions	$ 12.176 Millions
Lftd Partners Inc	11.18	$ 36.921 Millions	$ 3.303 Millions
Petvivo Holdings Inc	11.10	$ 0.791 Millions	$ 0.071 Millions
Uniqure N v	10.98	$ 16.098 Millions	$ 1.466 Millions
National Healthcare Corp	10.92	$ 1,517.781 Millions	$ 138.939 Millions

Date modified: 2026-07-07T09:43:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.